Sarah Kathryn Rouan Viking Therapeutics, Inc. (VKTX) insider trading activity

Sarah Kathryn Rouan is Director of Viking Therapeutics, Inc.. Currently has a direct ownership of 0 shares of VKTX, which is worth approximately $0. The most recent transaction as insider was on Feb 08, 2024, when has been sold 25,000 shares (Common stock, par value $0.00001 per share) at a price of $28.05 per share, resulting in proceeds of $701,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

n/a 12M change

Total Value Held $0

Sarah Kathryn Rouan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 08 2024	SELL Open market or private sale	$701,250 $28.05 p/Share	25,000 Reduced 100.0%	0 Common stock, par valu...
Feb 08 2024	BUY Exercise of conversion of derivative security	$208,000 $8.32 p/Share	25,000 Added 50.0%	25,000 Common stock, par valu...
Jan 19 2024	SELL Open market or private sale	$691,500 $23.05 p/Share	30,000 Reduced 100.0%	0 Common stock, par valu...
Jan 19 2024	BUY Exercise of conversion of derivative security	$249,600 $8.32 p/Share	30,000 Added 50.0%	30,000 Common stock, par valu...

Also insider at

NAVB

NAVIDEA BIOPHARMACEUTICALS, INC. Healthcare

Director

SKR